SEARCH RESULT

Total Matching Records found : 151

Why Novartis case will help innovation-Achal Prabhala and Sudhir Krishnaswamy

-The Hindu The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness On April 1, 2013, the Supreme Court upheld the Intellectual Property Appellate Board's decision to deny patent protection to Novartis's application covering a beta crystalline form of imatinib -the medicine Novartis brands as Glivec, and which is very effective against the form of cancer known as chronic myeloid leukaemia (CML). The...

More »

Shortage of MTP pills, thanks to tighter norms of Food and Drug Administration -Pratibha Masand

-The Times of India MUMBAI: Bhavin Dave was married for six weeks when his wife realized she was pregnant. Both rushed to a doctor, who said the best way to deal with the unplanned pregnancy was to use a medical termination of pregnancy (MTP) drug. She prescribed the pills and that was when their ordeal began. Bhavin (name changed) scrambled from pharmacy to pharmacy with the prescription, but to no avail. He...

More »

More battles in store-Aarti Dhar

-The Hindu Well before the Supreme Court rejected Novartis' application for patent for Glivec (Gleevec in the U.S.), drawing attention to the dichotomy of generic and patented drugs, activists have been demanding access to expensive drugs used in the treatment of cancer, hepatitis C and serious HIV. Trastuzumab is one such, used in the treatment of HER2+ type of breast cancer, which affects about one in four patients with the disease. Rough...

More »

Calling big pharma’s bluff -Dwijen Rangnekar

-The Hindu The lesson from the Supreme Court ruling on Gleevec is that pharmaceutical multinational corporations need to focus research on genuine innovations rather than on ways to evergreen their patents The much awaited Supreme Court judgment on Gleevec has been delivered. Novartis has failed in reversing the rejection of its patent. And, predictably - like a scratched record - there have been suggestions that pharma investments in India will dry...

More »

CAG report puts Delhi government hospitals in a dock

-PTI The condition of government hospitals in Delhi drew a sharp criticism from Comptroller and Auditor General (CAG), which, in its report found several glaring shortcomings like unavailability of blood banks in five hospitals. The CAG today painted a sorry state of affairs at government hospitals in the national capital in its report for the fiscal year ending March 2012, which was tabled in Delhi Assembly. The government auditor said that scrutiny of...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close